Solventum

Bottom line

Solventum's NLP and machine learning coding platform, spun off from 3M Health Information Systems in 2024, is an enterprise-grade solution designed for large hospitals and health systems automating inpatient and outpatient coding workflows. It carries the legacy of one of the oldest players in computer-assisted coding, with a customer base built over decades of 3M's presence in the HIS market. However, public evidence of clinical performance, ROI, and user satisfaction is strikingly thin. The platform is priced for enterprise buyers only, with no publicly listed tiers for smaller practices or individual coders.

For large health systems already embedded in the 3M ecosystem or evaluating coding automation as part of a broader revenue cycle management overhaul, Solventum merits consideration alongside competitors like Nuance, Optum, and Epic's native tools. For smaller organizations, solo practitioners, or teams seeking transparent pricing and robust third-party validation, the evidence gap and enterprise-only positioning make this a poor fit. The lack of peer-reviewed outcomes data and limited clinician feedback in public forums suggest caution for buyers prioritizing evidence-based purchasing decisions.

Pricing is opaque. The vendor lists enterprise-only contracts with no public per-seat or per-encounter figures. Clinician feedback on forums confirms that single-user or small-team pricing is prohibitively expensive or unavailable. Expect annual contracts, implementation fees, and ongoing support costs that make sense only at institutional scale.

Why we picked it

Solventum was selected for review based on its market position as the successor to 3M Health Information Systems, a legacy vendor with decades of presence in computer-assisted coding and clinical documentation improvement. The platform's stated use of natural language processing and machine learning to automate coding across both inpatient and outpatient settings places it in the high-stakes revenue cycle management category, where even modest accuracy gains can translate to millions of dollars in correctly captured reimbursement for large health systems.

The 3M lineage matters. Before the 2024 spin-off, 3M HIS was a known competitor to Nuance, TruCode, and Optum in the coding automation space, with a customer base spanning academic medical centers, community hospitals, and integrated delivery networks. The transition to Solventum theoretically preserves that installed base while allowing the new entity to focus exclusively on healthcare technology without the diversified manufacturing portfolio that characterized 3M.

However, this review does not designate Solventum as a top pick within its category. The evidence base is too thin, pricing is too opaque, and user feedback is too sparse to justify that designation. What Solventum does best relative to its category is leverage a long legacy and presumed enterprise integration maturity. What it fails to do is make a public, transparent case for why a CMIO should choose it over competitors with more accessible performance data and clearer value propositions.

The platform was included in this review to serve health systems conducting formal RFPs for coding automation and to provide a counterpoint to vendor marketing claims. Buyers deserve to know when public evidence is absent, and in this case, the absence is striking enough to warrant documentation.

What it does well

Solventum's core strength lies in automated coding workflow acceleration for high-volume institutional settings. The platform uses natural language processing to parse clinical documentation and suggest ICD-10, CPT, and HCPCS codes, reducing the manual burden on certified coders and theoretically improving coding accuracy and completeness. This is particularly valuable in inpatient settings where diagnostic-related group assignment errors can result in significant revenue leakage or compliance risk.

The platform operates across both inpatient and outpatient environments, a flexibility that matters for integrated delivery networks managing coding workflows across multiple care settings. Many competing tools specialize in one or the other, requiring health systems to maintain separate vendor relationships and training programs. Solventum's unified approach theoretically simplifies vendor management and allows coders to work within a single interface regardless of encounter type.

As the successor to 3M HIS, Solventum inherits a legacy customer base and, presumably, mature integrations with major EHR vendors. While the company has not published a current integration matrix, the decades-long presence of 3M coding tools in the market suggests compatibility with Epic, Cerner Oracle Health, Meditech, and other widely deployed systems. For health systems already using 3M coding products, migration to the Solventum-branded successor likely involves less friction than switching to a competing vendor.

The VLab training platform, though criticized for usability issues in clinician forums, indicates that Solventum provides structured onboarding resources for coding students and new hires. This is a non-trivial feature for hospitals managing coder turnover or onboarding new staff during revenue cycle optimization projects. Competing platforms often rely on vendor-led training sessions that are expensive and difficult to scale.

Where it falls short

The most glaring weakness is the absence of public evidence. Zero peer-reviewed studies in PubMed examine the coding accuracy, revenue impact, or workflow efficiency of Solventum's platform. The five PubMed citations that surface when searching for Solventum are all about unrelated product lines: dental composite materials and wound care dressings. This reflects the reality that Solventum is a diversified healthcare company, and its coding platform is just one division among many. For a tool used to make high-stakes reimbursement decisions, the lack of third-party validation is a serious red flag.

Clinician feedback on forums is sparse and, where it exists, predominantly negative. Coders on r/MedicalCoding report that the VLab training platform is buggy, requires specific browsers, and demands cache and cookie cleanup followed by full browser restarts to log in reliably. One user reported needing to contact AHIMA support because the platform was too expensive for a single user, suggesting that even educational access involves non-trivial cost barriers. Another described the institutional inpatient auditing process as manual, using email and Excel spreadsheets, while evaluating Solventum as a potential upgrade. This suggests that even organizations considering the platform are currently operating without it, undermining the notion that it is a market-standard solution.

Pricing opacity is a structural problem. The vendor lists enterprise-only contracts with no publicly accessible tier information beyond a placeholder zero-dollar entry. This locks out solo practitioners, small coding firms, and even mid-sized hospitals that lack the budget or IT infrastructure for enterprise software procurement. Competing tools from Nuance and Dolbey offer tiered pricing with at least some transparency for smaller buyers. Solventum's enterprise-only model signals that it is not designed for, and does not want to serve, the smaller end of the market.

Support friction is another recurring theme. Multiple Reddit users advised calling AHIMA rather than relying on direct vendor support, suggesting either that Solventum's customer service is inadequate or that AHIMA serves as a necessary intermediary for educational and small-user access. Either scenario is a poor signal for prospective buyers expecting responsive vendor support during implementation and daily use.

Deployment realities

Deploying Solventum at institutional scale requires significant IT commitment. As an enterprise coding platform, it must integrate with the organization's EHR, revenue cycle management system, and potentially separate clinical documentation improvement tools. These integrations typically involve HL7 or FHIR interfaces, custom field mapping, and ongoing maintenance as EHR vendors release updates. Health systems should budget for at least six months of implementation time, including interface development, workflow redesign, and coder training.

Training overhead is non-trivial, as evidenced by the VLab platform's existence and the usability complaints surfaced in clinician forums. Coders accustomed to manual workflows or legacy 3M tools will require structured onboarding, and the browser-specific quirks reported by users suggest that IT departments will field support tickets during the transition period. Organizations should plan for reduced coder productivity during the first 60 to 90 days post-deployment while staff adapt to the new interface and learn to validate machine-suggested codes rather than manually assigning them from scratch.

Change management is critical. Automated coding tools alter the role of certified coders from primary code assigners to validation specialists who review and correct machine output. This shift requires buy-in from coding leadership, clear communication about job security, and potentially revised performance metrics. Institutions that fail to manage this cultural transition risk coder resistance, workarounds that undermine the tool's value, or turnover among experienced staff who feel their expertise is being devalued.

Pricing realities

Solventum's pricing is structured exclusively for enterprise buyers, with no public disclosure of per-seat, per-encounter, or modular costs. The single pricing tier listed is labeled Enterprise at zero dollars per month and per year, a placeholder that signals the vendor expects buyers to request custom quotes based on organizational size, encounter volume, and scope of deployment. This is standard practice among enterprise HIS vendors but creates opacity that disadvantages smaller buyers and makes cost comparison across vendors difficult.

Clinician feedback confirms that single-user pricing is either unavailable or prohibitively expensive. One coder on r/MedicalCoding stated bluntly that no one can afford to buy a single Solventum user license and advised contacting AHIMA or the user's educational institution for VLab access instead. This suggests that even training-level access involves costs beyond the reach of individual professionals, a sharp contrast to competitors like TruCode or Dolbey that offer individual or small-team subscriptions.

Hidden costs are likely substantial. Enterprise coding platforms typically charge for initial implementation, ongoing support, annual software maintenance, and per-API-call fees if the tool is used to automate coding in real time via EHR integrations. Health systems should expect six-figure annual contracts for mid-sized deployments and seven-figure costs for large academic medical centers or integrated delivery networks. Contract terms likely include annual renewals with auto-escalation clauses and exit penalties that make vendor switching costly once the platform is embedded in daily workflows.

Compliance + integration depth

Solventum's platform is presumed to be HIPAA-compliant, a baseline requirement for any enterprise HIS tool handling protected health information. However, the vendor's website does not publicly list SOC 2, HITRUST, or ISO 27001 certifications, nor does it provide a trust center with third-party audit reports. Buyers conducting formal security assessments should request these documents directly during the RFP process and verify that Solventum maintains the same compliance posture as legacy 3M HIS products.

EHR integration depth is unclear. The vendor does not publish a current integration matrix, and no Reddit or PubMed sources name specific EHR vendors or describe whether integrations are read-only, bi-directional, or embedded within the EHR interface. Given the 3M legacy, it is reasonable to assume compatibility with Epic, Cerner Oracle Health, and Meditech, but prospective buyers should confirm this during vendor demonstrations and request evidence of successful deployments at reference sites using the same EHR platform.

The platform does not carry FDA clearance, nor would it be expected to. Coding automation tools are not classified as medical devices and do not make clinical diagnostic or treatment decisions. However, they do influence reimbursement and compliance, so buyers should verify that the tool's code suggestion logic adheres to current CMS coding guidelines and is updated promptly when ICD-10 or CPT codes are revised or retired.

Vendor stability + roadmap

Solventum was spun off from 3M in 2024 as a standalone healthcare company, a significant corporate event that carries both opportunity and risk. On the positive side, the spin-off allows Solventum to focus exclusively on healthcare technology without competing for capital and executive attention against 3M's diversified industrial and consumer businesses. The company inherited a large customer base, decades of product development, and a recognized brand in health information systems.

On the risk side, spin-offs often involve organizational disruption, leadership turnover, and shifts in product strategy as the new entity establishes its identity. Buyers should ask about retention of key engineering and product leadership from the 3M HIS division, the roadmap for product updates, and whether customer support teams remained intact post-separation. The absence of public statements about Solventum's coding platform specifically, as opposed to its other healthcare products, suggests that the division may not be a top strategic priority within the new company.

The publicly stated roadmap is unavailable. The vendor's website emphasizes its diversified healthcare portfolio, including dental, wound care, and orthopedic products, but does not highlight the coding platform as a flagship offering. This lack of visibility is concerning for buyers who need assurance that the platform will receive continued investment, feature updates, and compatibility maintenance as EHR vendors evolve. Prospective customers should request a detailed product roadmap and multi-year commitment to support as part of contract negotiations.

How it compares

Solventum competes directly with Nuance, Optum, TruCode, Dolbey, and Epic's native coding tools. Nuance, now owned by Microsoft, offers Dragon Medical One for clinical documentation and separate computer-assisted coding tools with strong market share in academic medical centers. Nuance wins when buyers prioritize voice recognition integration and Microsoft ecosystem compatibility. Solventum may win when buyers already use legacy 3M products and prefer vendor continuity over feature richness.

Optum's coding automation tools are part of a broader revenue cycle management suite and appeal to health systems seeking end-to-end RCM solutions from a single vendor. Optum wins when buyers want bundled RCM services including denials management, claims scrubbing, and analytics. Solventum wins when buyers want a best-of-breed coding tool that integrates with existing RCM platforms rather than replacing them. However, Optum's public evidence base is also thin, making head-to-head comparison difficult.

TruCode, now part of Experian Health, offers modular coding automation with transparent pricing tiers and a focus on ambulatory and hospital outpatient departments. TruCode wins when buyers need a solution for outpatient coding specifically and value transparent pricing. Solventum theoretically wins when buyers need unified inpatient and outpatient coding, but the lack of public pricing makes cost comparison impossible. Dolbey's Fusion CAC platform is another competitor with a similar enterprise focus and similarly opaque pricing, suggesting that the enterprise coding market as a whole suffers from transparency deficits.

Epic's native coding tools, available to Epic customers as part of the EHR platform, win when buyers prioritize tight integration and single-vendor support. Epic's tools are not best-of-breed, and many Epic customers supplement them with third-party coding platforms like Solventum or Nuance. Solventum wins in this scenario when it demonstrably outperforms Epic's native tools in accuracy or coder productivity, but the absence of public performance data makes that case hard to validate. Buyers should request side-by-side benchmark data during the RFP process and insist on reference sites that have replaced Epic's native tools with Solventum.

What clinicians say

Clinician feedback on Solventum is sparse and predominantly negative, with only eight mentions identified across medical and coding forums. Coders on r/MedicalCoding reported that the VLab training platform is buggy and requires specific browser configurations, cache and cookie cleanup, and multiple steps to achieve reliable login. One user stated: "The VLab site is pretty buggy. You gotta use a specific browser and do 24 different things to make sure everything is perfect. Definitely call AHIMA." This suggests that even the training platform, which should serve as a low-friction onboarding tool, creates usability barriers.

Pricing concerns dominate the limited feedback. One coder bluntly stated: "Call AHIMA. I don't think anyone can afford to buy 1 single user for the Solventum product." This confirms that the enterprise-only pricing model locks out individual professionals and small teams, a significant limitation for coders seeking to use the tool for continuing education or freelance work. Another user described their hospital's inpatient auditing process as manual, using email and Excel, while evaluating Solventum as a potential upgrade. This suggests the platform is aspirational for some organizations but not yet widely adopted even among institutions actively seeking coding automation.

One mention on r/nursing referenced Solventum in the context of MRSA decolonization products, specifically Nozin and Solventum wound care solutions. This is unrelated to the coding platform and reflects the company's diversified product portfolio. The absence of substantive discussion about the coding platform's clinical or operational impact on physician, nursing, or health IT forums is itself a meaningful signal. Either the tool has limited market penetration, users are not engaged enough to discuss it publicly, or dissatisfaction is high enough that users avoid advocacy. None of these interpretations favor Solventum.

What the literature says

The peer-reviewed literature contains zero studies evaluating Solventum's coding platform. A PubMed search for Solventum returns five recent citations, all of which examine unrelated products: dental composite materials, ceramic crown luting agents, antibacterial bonding agents, and closed-incision negative pressure therapy devices. These studies reflect Solventum's diversified healthcare product portfolio but provide no evidence about the coding platform's accuracy, revenue impact, or workflow efficiency.

This evidence gap is striking and disqualifying for buyers who prioritize peer-reviewed validation. Competing coding platforms from Nuance and Optum have similarly thin public evidence bases, suggesting that the computer-assisted coding industry as a whole suffers from a lack of independent research. However, the absence of even vendor-sponsored case studies or white papers in indexed journals is a red flag. Health systems considering Solventum should demand internal performance data from reference sites, including before-and-after coding accuracy rates, revenue cycle impact, and coder productivity metrics, and should verify those claims through direct site visits rather than vendor-curated testimonials.

The lack of literature also means there is no evidence addressing algorithmic bias, code suggestion accuracy across specialty areas, or error patterns that might lead to compliance risk. Coding errors can result in upcoding accusations, audits, and financial penalties, so the absence of third-party validation of the platform's suggestion logic is a material risk. Buyers should request transparent documentation of the NLP and machine learning models used, including training data sources, validation methodologies, and performance across demographic and diagnostic subgroups.

Who it's for

Solventum is designed for large hospitals, academic medical centers, and integrated delivery networks with enterprise IT budgets, mature revenue cycle management programs, and the organizational capacity to manage complex vendor integrations. It is a reasonable fit for health systems already using legacy 3M HIS products and seeking continuity with a known vendor, particularly if those organizations have achieved measurable ROI from existing 3M tools and prefer to extend rather than replace their current infrastructure.

The platform is a poor fit for solo practitioners, small physician groups, independent coding firms, and mid-sized community hospitals without dedicated health IT departments. The enterprise-only pricing model, implementation complexity, and lack of transparent performance data make Solventum inaccessible or unattractive to smaller buyers. Clinicians seeking coding automation for individual use should consider TruCode's modular offerings or Dolbey's smaller-scale deployments, both of which offer more accessible entry points despite their own transparency limitations.

Even for large health systems, Solventum is appropriate only when the organization is conducting a formal RFP process, comparing multiple vendors, and insisting on reference site visits and performance benchmarking. Buyers who accept vendor marketing claims at face value or who choose Solventum based solely on legacy 3M relationships without validating current performance risk overpaying for a tool that may underperform competitors. The evidence gap means that due diligence must be exhaustive, and buyers should walk away if the vendor cannot provide verifiable performance data from similar-sized deployments.

The verdict

Solventum's coding platform cannot be recommended with confidence based on the available evidence. The absence of peer-reviewed studies, the scarcity of clinician feedback, the opacity of pricing, and the usability complaints about the VLab training platform all point to a product that has not made a public case for its value. For a tool that automates high-stakes reimbursement decisions, the lack of third-party validation is disqualifying unless offset by compelling internal performance data verified through rigorous due diligence.

If your organization is a large health system already embedded in the 3M ecosystem, conducting a formal RFP for coding automation, and prepared to demand performance benchmarks and reference site validation, Solventum merits inclusion in the vendor evaluation process alongside Nuance, Optum, and TruCode. If the vendor can demonstrate superior coding accuracy, measurable revenue cycle impact, and mature EHR integrations at reference sites comparable to your organization, it may prove to be the right choice. However, default to competitors with more transparent evidence unless Solventum earns its place through head-to-head comparison.

If your organization is a mid-sized hospital, a small physician group, or an individual coder seeking automation tools, skip Solventum entirely. The enterprise-only pricing model, implementation complexity, and lack of accessible onboarding resources make it a poor fit. Look instead at TruCode for modular outpatient coding, Dolbey for smaller hospital deployments, or Epic's native tools if you are already on Epic and willing to accept good-enough functionality in exchange for tight integration. The evidence gap surrounding Solventum means that smaller buyers are better served by vendors with more transparent value propositions, even if those vendors also lack robust peer-reviewed validation.